Back

False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study

2 September 2024 (10:00 - 10:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Emel Kaplan

University Hospital Basel, Basel (Switzerland)

3 More presentations in this session

Presentation thumbnail
Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria
Doctor A. Cai (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study
Mr P. Charleux (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of cardiovascular disease risk: findings from the National Survey of Health and Development Cohort.
Doctor E. Agwara (Cambridge, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Troponin antibodies and macrotroponin: a common cause of troponin I elevation in elite endurance athletes
thumbnail
Congress Presentation
The hidden role of cardiac troponin interferents in diagnosis and clinical management of myocarditis: a single center experience.
thumbnail
Congress Presentation
Troponin elevation and vascular involvement post-COVID-19

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources